Literature DB >> 11326818

Revised international definitions in tuberculosis control.

.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11326818

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  72 in total

1.  Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.

Authors:  O S Toungoussova; A O Mariandyshev; G Bjune; D A Caugant; P Sandven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-03       Impact factor: 3.267

2.  Did we reach the 2005 targets for tuberculosis control?

Authors:  Christopher Dye; Mehran Hosseini; Catherine Watt
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408

3.  Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis.

Authors:  Seok-Yong Eum; Ye-Jin Lee; Jin-Hong Min; Hyun-Kyung Kwak; Min-Sun Hong; Ji-Hye Kong; Soo-Hee Hwang; Seung-Kyu Park; Jason J Leblanc; Laura E Via; Clifton E Barry; Sang-Nae Cho
Journal:  Respiration       Date:  2010-02-10       Impact factor: 3.580

4.  Comparative proteomic analysis of serum diagnosis patterns of sputum smear-positive pulmonary tuberculosis based on magnetic bead separation and mass spectrometry analysis.

Authors:  Jiyan Liu; Tingting Jiang; Feng Jiang; Dandan Xu; Liliang Wei; Chong Wang; Zhongliang Chen; Xing Zhang; Jicheng Li
Journal:  Int J Clin Exp Med       Date:  2015-02-15

5.  Serum protein profiling of smear-positive and smear-negative pulmonary tuberculosis using SELDI-TOF mass spectrometry.

Authors:  Qi Liu; Xuerong Chen; Chaojun Hu; Renqing Zhang; Ji Yue; Guihui Wu; Xiaoping Li; Yunhong Wu; Fuqiang Wen
Journal:  Lung       Date:  2009-12-09       Impact factor: 2.584

6.  Treatment outcome of extra-pulmonary tuberculosis in Finland: a cohort study.

Authors:  Tuula Vasankari; Pekka Holmström; Jukka Ollgren; Kari Liippo; Petri Ruutu
Journal:  BMC Public Health       Date:  2010-07-06       Impact factor: 3.295

7.  Deaths among tuberculosis cases in Shanghai, China: who is at risk?

Authors:  Xin Shen; Kathryn Deriemer; Zheng'an Yuan; Mei Shen; Zhen Xia; Xiaohong Gui; Lili Wang; Jian Mei
Journal:  BMC Infect Dis       Date:  2009-06-17       Impact factor: 3.090

Review 8.  Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis.

Authors:  Dick Menzies; Andrea Benedetti; Anita Paydar; Sarah Royce; Pai Madhukar; William Burman; Andrew Vernon; Christian Lienhardt
Journal:  PLoS Med       Date:  2009-09       Impact factor: 11.069

9.  Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis.

Authors:  Won-Jung Koh; O Jung Kwon; Gee Young Suh; Man Pyo Chung; Hojoong Kim; Nam Yong Lee; Tae Sung Kim; Kyung Soo Lee
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

Review 10.  Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis.

Authors:  Dick Menzies; Andrea Benedetti; Anita Paydar; Ian Martin; Sarah Royce; Madhukar Pai; Andrew Vernon; Christian Lienhardt; William Burman
Journal:  PLoS Med       Date:  2009-09-15       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.